azomycin has been researched along with Brain Disorders in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (33.33) | 18.7374 |
1990's | 7 (58.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (8.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bibolini, J; Cicora, F; Escurra, V; González, I; Petroni, J; Roberti, J | 1 |
Edwards, MS; Gordon, DG; Levin, VA; Phillips, TL | 1 |
Hochmann, A; Lambert, PH; Poltera, AA | 1 |
Ho, KC; Kun, LE; Moulder, JE | 1 |
Barreira, AA; Flores-Vieira, CL | 1 |
Barreira, AA; Chimelli, L; Flores-Vieira, CL; França Fernandes, RM | 1 |
Bouteille, B; Dumas, M | 1 |
Pays, JF | 1 |
Adams, JH; Hunter, CA; Jennings, FW; Kennedy, PG; Murray, M | 1 |
Jennings, FW | 2 |
Bleehen, NM; Roberts, JT; Walton, MI; Workman, P | 1 |
1 review(s) available for azomycin and Brain Disorders
Article | Year |
---|---|
[Human American trypanosomiasis 90 years after its discovery by Carlos Chagas. II--Clinical aspects, physiopathology, diagnosis and treatment].
Topics: Brain Diseases; Chagas Cardiomyopathy; Chagas Disease; Child; Child, Preschool; Diagnosis, Differential; Disease Vectors; Double-Blind Method; Follow-Up Studies; Gastrointestinal Diseases; Humans; Immunization; Immunologic Deficiency Syndromes; Longitudinal Studies; Myocarditis; Nitroimidazoles; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Trypanocidal Agents; Vaccines | 1999 |
11 other study(ies) available for azomycin and Brain Disorders
Article | Year |
---|---|
Cerebral trypanosomiasis in a renal transplant recipient.
Topics: Adult; Brain Diseases; Central Nervous System Protozoal Infections; Chagas Disease; Humans; Kidney Transplantation; Male; Nitroimidazoles; Tomography, X-Ray Computed; Trypanocidal Agents | 2014 |
Misonidazole neurotoxicity in rats: Part I. Evaluation of misonidazole neurotoxicity in rats by analysis of brain stem auditory and cortical evoked potentials.
Topics: Animals; Auditory Cortex; Brain Diseases; Brain Stem; Cerebral Cortex; Evoked Potentials, Auditory; Male; Misonidazole; Nitroimidazoles; Rats; Rats, Inbred Strains; Reaction Time | 1984 |
Trypanosoma brucei brucei: the response to Melarsoprol in mice with cerebral trypanosomiasis. An immunopathological study.
Topics: Animals; Antigen-Antibody Complex; Arsenicals; Brain; Brain Diseases; Chloroquine; Fluorescent Antibody Technique; Injections, Intraperitoneal; Injections, Intravenous; Melarsoprol; Mice; Nitroimidazoles; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 1981 |
Fatal misonidazole-induced encephalopathy: an RTOG case report.
Topics: Brain Diseases; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Female; Humans; Middle Aged; Misonidazole; Nitroimidazoles; Palatal Neoplasms; Tongue Neoplasms | 1982 |
Experimental benznidazole encephalopathy: I. Clinical-neurological alterations.
Topics: Animals; Ataxia; Brain Diseases; Cranial Nerves; Dogs; Dose-Response Relationship, Drug; Humans; Male; Motor Activity; Neurotoxins; Nitroimidazoles; Posture; Quadriplegia; Reflex; Reflex, Stretch; Trypanocidal Agents | 1997 |
Experimental benznidazole encephalopathy: II. Electroencephalographic and morphological alterations.
Topics: Animals; Brain; Brain Diseases; Cerebellum; Dogs; Electroencephalography; Microglia; Nerve Degeneration; Neurons; Neurotoxins; Nitroimidazoles; Peripheral Nerves; Reference Values; Trypanocidal Agents | 1997 |
[Current status of trypanosomiasis].
Topics: Africa; Animals; Autoantibodies; Blood-Brain Barrier; Brain Diseases; Follow-Up Studies; Forecasting; Humans; Incidence; Melarsoprol; Nitroimidazoles; Pentamidine; Population Surveillance; Protozoan Vaccines; Recurrence; Social Problems; Socioeconomic Factors; Survival Rate; Trypanocidal Agents; Trypanosoma; Trypanosomiasis, African | 1997 |
Subcurative chemotherapy and fatal post-treatment reactive encephalopathies in African trypanosomiasis.
Topics: Adolescent; Adult; Animals; Arsenicals; Brain; Brain Diseases; Child; Child, Preschool; Diminazene; Female; Humans; Male; Mice; Nitroimidazoles; Polymerase Chain Reaction; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 1992 |
Chemotherapy of CNS-trypanosomiasis: combination chemotherapy with a 5-nitroimidazole (MK 436), an arsenical (Cymelarsan) and suramin.
Topics: Animals; Arsenicals; Brain Diseases; Disease Models, Animal; Drug Therapy, Combination; Female; Mice; Nitroimidazoles; Suramin; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 1991 |
Chemotherapy of CNS-trypanosomiasis: the combined use of the arsenicals and nitro-compounds.
Topics: Animals; Antiprotozoal Agents; Arsenicals; Brain Diseases; Drug Synergism; Drug Therapy, Combination; Female; Ketoconazole; Metronidazole; Mice; Nifurtimox; Nitro Compounds; Nitroimidazoles; Oxidation-Reduction; Suramin; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 1991 |
A clinical phase I toxicity study of Ro 03-8799: plasma, urine, tumour and normal brain pharmacokinetics.
Topics: Astrocytoma; Brain; Brain Diseases; Brain Neoplasms; Dose-Response Relationship, Drug; Drug Evaluation; Humans; Kinetics; Neoplasms; Nitroimidazoles | 1986 |